Tiziana Life Sciences announced the appointment of Professor Roberto Pellicciari to the company's Scientific Advisory Board and as a consultant to the company. Professor Pellicciari was the co-founder and remains Head of Medicinal Chemistry at Intercept Pharmaceuticals Inc. Professor Pellicciari is presently Professor of Medicinal Chemistry at the University of Perugia in Italy and has held a number of prestigious scientific posts.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.8 USD | +1.69% | +8.11% | +42.86% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+42.86% | 79.86M | |
+34.14% | 51.51B | |
-6.54% | 39.03B | |
+34.92% | 38.91B | |
-12.11% | 26.68B | |
+12.62% | 26.13B | |
-13.43% | 19.91B | |
+43.73% | 13.71B | |
+31.81% | 12.38B | |
-4.54% | 11.74B |
- Stock Market
- Equities
- TLSA Stock
- News Tiziana Life Sciences Ltd
- Tiziana Life Sciences Appoints Roberto Pellicciari to the Scientific Advisory Board